Dual Size/Charge‐Switchable Nanocatalytic Medicine for Deep Tumor Therapy

Abstract Elevating intratumoral levels of highly toxic reactive oxygen species (ROS) by nanocatalytic medicine for tumor‐specific therapy without using conventional toxic chemodrugs is recently of considerable interest, which, however, still suffers from less satisfactory therapeutic efficacy due to...

Full description

Bibliographic Details
Main Authors: Wencheng Wu, Yinying Pu, Jianlin Shi
Format: Article
Language:English
Published: Wiley 2021-05-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202002816